Orbimed’s $30 Million Investment into Lifecell International

IndusLaw advised Orbimed on the deal, while Lakshmikumaran & Sridharan advised LifeCell International.

Orbimed announced its investment of Approx. $30 million in Lifecell International.  

LifeCell International Private Limited operates as a healthcare firm. The Company provides biobank and diagnostic services such prenatal and newborn screening, genetic testing, and genetic counselling. LifeCell International serves customers worldwide. 

OrbiMed Advisors operates as a fund management company. The Company manages funds and invests in the healthcare industries. OrbiMed Advisors serves customers worldwide. 

The IndusLaw team was led by Partners Kartik Ganapathy (Picture), Jinni Sinha, Principal Associate Chitvan Bakshi and Associate Ekta Yadav. Diligence team consisted of Partner Revathy Muralidharan and Associate Anushree Kacker, Nilima Rajdev, Nikunj Poddar.

Lakshmikumaran & Sridharan team consisted of executive partner Badri Narayanan, partner Gaurav Dayal and associates Anmol Jain and Sumedha Kalra.

Involved fees earner: Chitvan Bakshi – IndusLaw; Kartik Ganapathy – IndusLaw; Anushree Kacker – IndusLaw; Revathy Muralidharan – IndusLaw; Nilima Pant – IndusLaw; Nikunj Poddar – IndusLaw; Jinni Sinha – IndusLaw; Ekta Yadav – IndusLaw; Gaurav Dayal – Lakshmikumaran & Sridharan ; Anmol Jain – Lakshmikumaran & Sridharan ; Sumedha Kalra – Lakshmikumaran & Sridharan ; Badri Narayanan – Lakshmikumaran & Sridharan ;

Law Firms: IndusLaw; Lakshmikumaran & Sridharan ;

Clients: LifeCell International ; OrbiMed;


Author: Alejandro Girola